Benedikt Schrage Profile picture
Cardiologist and clinician scientist | UKE, Hamburg and KI, Stockholm | #heartfailure #cardiogenicshock #mcs
Mar 2, 2023 10 tweets 10 min read
💡New research from our group @ESC_Journals indicates that #MCS might improve outcomes in patients with #heartfailure related #cardiogenicshock Let me walk you through it! Actually, #cardiogenicshock has, for many years, been seen as predominantly caused by #myocardialinfarction However, recent evidence suggests that non-ischemic causes match it in frequency and impact on outcomes ‼️
pubmed.ncbi.nlm.nih.gov/30879324/

onlinelibrary.wiley.com/doi/full/10.10…
Jun 19, 2022 32 tweets 7 min read
Last week, I successfully defended my PhD thesis @KarolinskaInstitutet This was an amazing journey centered around a controversial topic: ICDs for the primary prevention of SCD in HFrEF. Let´s have a look: 1/x Two landmark RCTs, MADIT II and SCD-HeFT, have established the concept of ICDs for the primary prevention of SCD in patients with HFrEF by showing a survival benefit with this approach. nejm.org/doi/full/10.10… nejm.org/doi/full/10.10… 2/x
Oct 9, 2020 16 tweets 10 min read
Fresh off the press: Our new manuscript on LV unloading in cardiogenic shock patients treated with VA-ECMO!
ahajournals.org/doi/abs/10.116…
A thread
1/14 In patients with severe cardiogenic shock, VA-ECMO is a feasible tool to provide sufficient circulatory support. However, it comes with a major limitation: Increase in LV afterload via retrograde perfusion of the aorta
2/14